Device / Technology News

RSS

Italian patent issued for NPM1 to test patients with AML

Xenomics, Inc., a developer of transrenal molecular diagnostics, announced today that a key Italian patent covering a unique diagnostic application with critical significance for patients with acute myeloid leukemia (AML) has issued.

16 Dec 2009

U.S. patent for new bioadhesive drug delivery system awarded to SRI International

SRI International, an independent nonprofit research and development organization, announced today the award of U.S. patent 7,592,021 for a new bioadhesive drug delivery system that enables enhanced release of drugs through the human body's mucous membranes.

16 Dec 2009

Researchers develop new electrophoretic method for detecting MIRCERA and EPO in blood

Austrian researchers have successfully developed a new electrophoretic method for detecting MIRCERA® and other erythropoietins (EPO) in the blood. The technique, using SARCOSYL-PAGE, has specifically enhanced sensitivity for MIRCERA, but does not alter the performance characteristics of SDS-PAGE for detecting other EPOs.

16 Dec 2009

NovaDel receives Issue Notification from USPTO for oral spray

NovaDel Pharma Inc., today announced that it received an Issue Notification from the United States Patent and Trademark Office (USPTO) for a new U.S. Patent, No. 7632517, entitled “Buccal, Polar and Non-polar Spray Containing Zolpidem,” which covers a method of treating insomnia by administering zolpidem to humans utilizing NovaDel’s oral spray technology.

16 Dec 2009

Zecotek Photonics' proprietary TGFL selected for research in flow cytometry

Zecotek Photonics Inc., a developer of leading-edge photonics technologies for medical, industrial and scientific markets, today announced that the National Cancer Institute, a division of the U.S. National Institutes of Health (NIH), has selected its proprietary Tunable Green Fiber Laser (TGFL) for research in flow cytometry.

16 Dec 2009

InSite Vision to advance new development candidate ISV-303

InSite Vision Incorporated, a company developing ophthalmic products for unmet eye care needs, today announced plans to advance new development candidate ISV-303, a topical anti-inflammatory product intended to reduce the pain and swelling associated with ocular surgery.

16 Dec 2009

Idaho Technology signs licensing agreement with Kapa Biosystems

Idaho Technology, Inc. has signed a licensing agreement with Kapa Biosystems, Inc., covering reagents or methods using SYBR® Green I technology and melting curve analysis for real time PCR.

16 Dec 2009

Results from five new studies on Genomic Health's Oncotype DX breast cancer test announced

Genomic Health, Inc. today announced results from five new studies on its Oncotype DX® breast cancer test, a multi-gene expression test that physicians currently use to predict the likelihood of chemotherapy benefit and recurrence risk for patients with early-stage breast cancer.

16 Dec 2009

FDA grants approval to market InterSol platelet additive solution

Fenwal Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today that the U.S. Food and Drug Administration has granted Fenwal approval to market InterSol® platelet additive solution.

15 Dec 2009

Vangent to implement SSO and Context Management capability in Military Health System

Vangent, Inc., a leading global provider of information management and strategic business process solutions, announced today it was awarded a $20 million contract by the Department of Defense (DoD) to implement an integrated Single Sign-On (SSO) and Context Management capability throughout the Military Health System.

15 Dec 2009

Patheon releases the first commercial shipments of SUMAVEL DosePro to Zogenix

Patheon a global provider of drug development and manufacturing services to the international pharmaceutical industry announced today that it has successfully released the first commercial shipments of SUMAVEL DosePro (sumatriptan injection) to Zogenix in anticipation of the planned U.S. commercial product launch scheduled in January 2010.

15 Dec 2009

Advanced Plasma Products launches its new TriClean Pro air sanitizer

Applied Science Products, Inc., announced today that its wholly owned subsidiary, Advanced Plasma Products Inc., has introduced its new TriClean Pro air sanitizer product powered by the company's newest advanced plasma generator design.

15 Dec 2009

State of Vermont implements Upp Technology's emergency management software

Upp Technology, a global provider of IT staffing services, implemented its irms|EM™ (Emergency Management) software for the State of Vermont within three weeks of selection of the solution. The software helped the State’s RSS (Receive, Stage, & Store) Warehouse become operational following just one day of training and distribute more than 2,000 piece of H1N1 Personal Protection Equipment (PPE) inventory to hospitals throughout the state.

15 Dec 2009

Spinal Restoration receives FDA SPA concurrence letter for its Phase 3 Biostat System study

Spinal Restoration, Inc. announced today it has received a Special Protocol Assessment concurrence letter from the U.S. Food and Drug Administration (FDA) for the design of its Phase 3 study of the Biostat System for the treatment of chronic discogenic low back pain.

15 Dec 2009

CALSTAR 6 recognised with the "Thermal Angel Lifesaver of the Year Award"

Estill Medical Technologies, Inc., a family-owned Texas company that produces the Thermal Angel Blood and IV Fluid Infusion Warmer, a patented medical device being utilized by U.S. hospitals, military and emergency responders to lessen the effects of fluid-induced hypothermia, named the CALSTAR 6 Unit of South Lake Tahoe as the first-ever recipient of their "Thermal Angel Lifesaver of the Year Award."

15 Dec 2009

Almac Discovery initiates Phase I clinical trial of intranasal Granisetron for CINV

Almac Discovery today announced the start of Phase I clinical trial of the novel intranasal Granisetron product. This product, which uses Archimedes' proprietary ChiSys® delivery technology, is being developed as a rapidly acting, well tolerated and convenient treatment for chemotherapy-induced nausea and vomiting (CINV).

15 Dec 2009

Tibotec Virco Virology BVBA acquires Ground Zero Software's LAB TRACKER HIV EMR system

Tibotec Virco Virology BVBA today announced the acquisition of LAB TRACKER(TM) HIV, a customized electronic medical record (EMR) system, from the company Ground Zero Software. LAB TRACKER(TM) HIV is a full-service, scalable software platform designed to meet the complex disease-management needs of health care providers who are treating people living with HIV/AIDS.

15 Dec 2009

Safe Life increases production of its A400 Series respirators

Safe Life Corp., an innovative antimicrobial company dedicated to developing novel technologies that prevent the spread of infection and disease, announced today that it is ramping production of its comfortable, breathable, A400 Series respirator to help healthcare providers and government agencies address the global shortage of N95 respirators during the H1N1 pandemic.

15 Dec 2009

Corporate Health IQ launched by Stratum Benefit Solutions

Stratum Benefit Solutions has launched Corporate Health IQ™, a 360-degree corporate health risk assessment and comprehensive strategy for designing and implementing integrated results-based incentives for corporate health and wellness programs.

15 Dec 2009

New website launched by A.D.A.M.

A.D.A.M., Inc., a leading provider of consumer health information, benefits technology solutions and award-winning education products, today announced the launch of www.adamimages.com.

15 Dec 2009